Collagen Peptide Supplementation for Knee Osteoarthritis After Total Knee Replacement

This study is looking at how a collagen peptide supplement, called SOLUGEL, might help people recovering from total knee replacement surgery (TKA) for knee osteoarthritis. Researchers want to see if taking SOLUGEL before surgery affects how your body's connective tissues heal and how well you recover. A placebo (maltodextrin, a sugar) will be compared to SOLUGEL. You might be able to join if you are 50-75 years old, have knee osteoarthritis, and are scheduled for a TKA at UAMS in Little Rock. The main goal is to measure changes in your body's genetic activity related to tissue healing two months after you start taking the supplement. The study plans to enroll 44 participants, but its current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 44 participants. It compares a collagen peptide supplement (SOLUGEL) to a placebo (maltodextrin).
What's involved
You would take a dietary supplement before your total knee replacement surgery. Tissue samples (ACL, synovial fluid, bone fragments) and blood will be collected during your surgery.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 2 months after supplementation, which suggests follow-up for at least that long.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05823727

Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA)

Recruiting
NAAges 50–75InterventionalTreatment
University of Arkansas
~44 participants
Updated 2026-05-27 on ClinicalTrials.gov
What's tested:SOLUGELPlacebo

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Effects of pre-surgical supplementation on mRNA transcription
Measured over 2 months after supplementation
Knee Osteoarthritis
1 sites across 1 states
Arkansas1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Males and Females, 50 to 75 years old
With a body mass index of 20.0 to 39.9 kg/m2
Diagnosed with primary osteoarthritis
Scheduled for a TKA at UAMS (two months prior to surgery) at UAMS
Live near Little Rock and scheduled to attend physical therapy in Little Rock
COVID-19 negative and/or asymptomatic.

Exclusion

Previously sustained serious knee injury or surgery to ACL in TKA knee
Females not postmenopausal
Having undergone hormone replacement therapy in the last 12 months.
Active diagnosis of blood borne infectious disease
  • Effects of pre-surgical supplementation on mRNA transcription2 months after supplementation

    Measuring mRNA in the anterior cruciate ligament extracted during surgery